Sign In
Buy DXCM
$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
This Southwest Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
08:04am, Friday, 26'th Jul 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Get Your Money Out of These 3 Nasdaq Stocks by the End of July
06:15am, Friday, 26'th Jul 2024
Nasdaq-listed stocks have sustained a prolonged rally in recent months, reflecting investor optimism and robust market sentiment. However, in recent days, we have seen a notable pullback in several ov
Dexcom plunges 40% after glucose monitor maker slashes sales forecast
05:23am, Friday, 26'th Jul 2024
Dexcom's shares sank about 38% in premarket trading on Friday after the medical device maker cut its annual revenue forecast, with analysts calling some of the issues 'self inflicted' rather than a br
DexCom Q2: Surprising Earnings Miss With Hints Of Competitive Pressures
01:25am, Friday, 26'th Jul 2024
DexCom reported disappointing earnings, missing estimates by 4% and lowering full-year growth expectations by ~$200 million. Sales in the U.S. market slowed, while international markets saw anemic gro
Watch These Dexcom Price Levels as Stock Plunges After Guidance Slashed
10:01pm, Thursday, 25'th Jul 2024
Shares in Dexcom (DXCM) lost more than a third of their value in extended trading Thursday after the medical devices company posted second-quarter results that came in below Wall Street expectations a
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
09:53pm, Thursday, 25'th Jul 2024
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) investors concerning the Company
DexCom, Inc. (DXCM) Q2 2024 Earnings Call Transcript
09:09pm, Thursday, 25'th Jul 2024
DexCom, Inc. (NASDAQ:DXCM ) Q2 2024 Earnings Conference Call July 25, 2024 4:30 PM ET Corporate Participants Sean Christensen - Vice President of Finance, and Investor Relations Kevin Sayer - Chairman
DexCom (DXCM) Q2 Earnings Surpass Estimates
06:15pm, Thursday, 25'th Jul 2024
DexCom (DXCM) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.34 per share a year ago.
Dexcom Stock Plummets on Earnings Miss, Guidance Cut
05:56pm, Thursday, 25'th Jul 2024
Shares of Dexcom (DXCM) tumbled over 40% in extended trading Thursday after the company reported second-quarter earnings that missed estimates and slashed its full-year revenue guidance.
Dexcom shares plummet 30% after company lowers fiscal year guidance
04:17pm, Thursday, 25'th Jul 2024
Dexcom shares plummet 30% after company lowers fiscal year guidance
CGM Sensor Demand Likely to Drive DexCom (DXCM) Q2 Earnings
08:36am, Tuesday, 23'rd Jul 2024
DexCom's (DXCM) second-quarter 2024 results are likely to reflect rising volumes across all channels.
The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific
04:46am, Tuesday, 16'th Jul 2024
DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific are included in this Analyst Blog.
Here's Why DexCom (DXCM) is a Strong Growth Stock
10:45am, Monday, 15'th Jul 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Buy 5 Medical Devices Stocks to Enhance Your Portfolio in 2H
09:12am, Monday, 15'th Jul 2024
We have narrowed our search to five Medical Instruments stocks. These are: DXCM, TMO, ISRG, ALC, HOLX.
2 Healthcare Stocks to Buy at a Discount
10:00am, Sunday, 14'th Jul 2024
Investors are showing varying degrees of appetite for the telehealth and diabetes care industries. Teladoc has undergone major changes in recent years, and investors are warily eyeing its path forward
